GB1350255A - Tablets having a sustained release of active substance - Google Patents

Tablets having a sustained release of active substance

Info

Publication number
GB1350255A
GB1350255A GB1813671A GB1813671A GB1350255A GB 1350255 A GB1350255 A GB 1350255A GB 1813671 A GB1813671 A GB 1813671A GB 1813671 A GB1813671 A GB 1813671A GB 1350255 A GB1350255 A GB 1350255A
Authority
GB
United Kingdom
Prior art keywords
sustained release
tablet
digestive juices
tablets
active substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1813671A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hassle AB
Original Assignee
Hassle AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hassle AB filed Critical Hassle AB
Publication of GB1350255A publication Critical patent/GB1350255A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1350255 Sustained release medicament HASSLE AB 28 May 1971 [4 June 1970] 18136/71 Heading A5B A sustained release tablet comprises one or more active substances soluble in digestive juices and a three dimensional network which (a) is insoluble in digestive juices, (b) constitutes less than 10% by weight of the tablet, (c) comprises at least one thermoplastic and/or resinous plastics material and, (d) has sufficient mechanical strength to delay leaching of the active substance(s) on contact with digestive juices but is broken down by intestinal peristaltic movement when the active substances have been leached out. Suitable plastics materials are: polyethylene, polypropylene, polymethyl methacrylate, polyvinyl acetate, polyvinyl chloride, ethylene/vinyl acetate copolymer, vinyl chloride/vinyl acetate -copolymer, silicone resin and polystyrene. The network may also comprise a waxy material, e.g. carnauba wax, beeswax, natural or synthetic paraffin wax or microcrystalline The tablet may be formed by compression of a granular mixture of the ingredients. Tablets are disclosed which comprises, (a) KC1, (b) caffeine and (c) FeSO 4 and ascorbic acid.
GB1813671A 1970-06-04 1971-05-28 Tablets having a sustained release of active substance Expired GB1350255A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE779170A SE353229B (en) 1970-06-04 1970-06-04

Publications (1)

Publication Number Publication Date
GB1350255A true GB1350255A (en) 1974-04-18

Family

ID=20272321

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1813671A Expired GB1350255A (en) 1970-06-04 1971-05-28 Tablets having a sustained release of active substance

Country Status (10)

Country Link
JP (1) JPS5443055B1 (en)
CA (1) CA951642A (en)
DE (1) DE2126810C3 (en)
DK (1) DK130387B (en)
FI (1) FI51900C (en)
FR (1) FR2104754B1 (en)
GB (1) GB1350255A (en)
NL (1) NL172824C (en)
NO (1) NO133220C (en)
SE (1) SE353229B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU604585B2 (en) * 1987-10-22 1990-12-20 Bristol-Myers Squibb Company Oral formulation of buspirone and salts thereof
CN112891314A (en) * 2021-01-27 2021-06-04 陕西思瑰瑞食品科技有限公司 Vitamin C and ferrous sulfate sustained and controlled release tablet and preparation method thereof

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI63335B (en) * 1979-02-02 1983-02-28 Orion Yhtymae Oy FARING REFERENCE FOR A TABLETTER WITH A LIGHT LIGHT OF AN EFFECTIVE
HU190619B (en) * 1983-11-11 1986-09-29 Bezzegh,Denes,Hu Process for producing tablets with controlled dissolution of active ingredients
DE3505433A1 (en) * 1985-02-16 1986-08-21 Basf Ag, 6700 Ludwigshafen DIRECT TABLETING AIDS
FR2595945B1 (en) * 1986-03-19 1990-01-19 Doms Laboratoires THEOPHYLLIN DELAY TABLET BASED ON P.V.C., AND PROCESS FOR PREPARING THE SAME

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2987445A (en) * 1958-10-10 1961-06-06 Rohm & Haas Drug composition

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU604585B2 (en) * 1987-10-22 1990-12-20 Bristol-Myers Squibb Company Oral formulation of buspirone and salts thereof
CN112891314A (en) * 2021-01-27 2021-06-04 陕西思瑰瑞食品科技有限公司 Vitamin C and ferrous sulfate sustained and controlled release tablet and preparation method thereof

Also Published As

Publication number Publication date
NL7107620A (en) 1971-12-07
NO133220B (en) 1975-12-22
FI51900B (en) 1977-01-31
FR2104754B1 (en) 1975-08-01
DE2126810C3 (en) 1980-11-20
JPS5443055B1 (en) 1979-12-18
CA951642A (en) 1974-07-23
FI51900C (en) 1977-05-10
NO133220C (en) 1976-03-31
FR2104754A1 (en) 1972-04-21
NL172824B (en) 1983-06-01
DE2126810B2 (en) 1980-03-27
DE2126810A1 (en) 1971-12-16
NL172824C (en) 1983-11-01
DK130387B (en) 1975-02-17
DK130387C (en) 1975-07-21
SE353229B (en) 1973-01-29

Similar Documents

Publication Publication Date Title
US3432592A (en) Injection-moulded oral medicament in solid form
US2996431A (en) Friable tablet and process for manufacturing same
US3096248A (en) Method of making an encapsulated tablet
AU565354B2 (en) Bioadhesive compositions and methods of treatment therewith
US3146169A (en) Pharmaceutical formulations and their manufacture
GR80109B (en) Crosslinked porous polymers for controlled drug devivery
IE781163L (en) Sustained release of veterinary medicaments
AU578577B2 (en) Devices for the controlled release of active substances, as well as process for the preparation thereof
KR900018238A (en) Novel polymer compositions
FR2409843A1 (en) MOLD FOR OBJECTS WITH LOCKED PARTS
NL169889B (en) PROCESS FOR THE PREPARATION OF FREE-LIQUID, BLOCK-RESISTANT, WATER-REDISPERSIBLE POWDER-BASED PLASTICS, METHOD FOR THE PREPARATION OF HYDRAULICALLY BINDING MASSES, AND FORMS MADE THEREOF
IE821861L (en) Pharmaceutical compositions
US2820741A (en) Aluminum aspirin granulation and method for making
GB1350255A (en) Tablets having a sustained release of active substance
AU528098B2 (en) Analgesic tablet
NL158516B (en) PROCEDURE FOR PREPARING POLYMER DISPERSIONS, PROCESS FOR MANUFACTURING FOELIES AND OTHER MOLDED PRODUCTS, MOLDED PRODUCTS MADE IN ACCORDANCE WITH THIS PROCESS AND POWDER PREPARATION PROCESS.
GB1296944A (en)
GB1457546A (en) Pharmaceutical preparations comprising cephalosporin derivatives
McGinity et al. Preparation and evaluation of a sustained morphine delivery system in rats
FR2436606A1 (en) PHARMACEUTICAL EXCIPIENT PRODUCT, ITS PREPARATION AND ITS USE IN THE PREPARATION OF SOLID DRUG FORMS
KR880009638A (en) Method for preparing granular material for external preparation of skin
USD217109S (en) Hamburger bun
ES2008753A6 (en) Release-controlled tablet type medicinal preparation based on buflomedil hydrochloride and manufacture
USD221348S (en) Food handling tongs or the like
Umanskiĭ et al. 3-dimensional growth (spheroid formation) of tumor cells in diffusion chambers

Legal Events

Date Code Title Description
PS Patent sealed
PE20 Patent expired after termination of 20 years